HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sergey Orlov Selected Research

Bevacizumab (Avastin)

10/2014Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.
6/2014A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).
2/2014Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sergey Orlov Research Topics

Disease

18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 08/2011
8Neoplasms (Cancer)
10/2023 - 04/2014
6Disease Progression
01/2023 - 02/2014
5Brain Neoplasms (Brain Tumor)
01/2022 - 02/2014
5Neutropenia
10/2019 - 02/2015
4Nausea
06/2023 - 09/2013
4Diarrhea
06/2023 - 09/2013
3Lung Neoplasms (Lung Cancer)
10/2023 - 01/2017
3Adenocarcinoma of Lung
06/2023 - 09/2013
3Acne Vulgaris
06/2023 - 09/2013
3Cough
06/2023 - 09/2013
3Exanthema (Rash)
06/2023 - 09/2013
3Fatigue
06/2023 - 09/2013
3Pain (Aches)
06/2023 - 09/2013
3Stomatitis
06/2023 - 09/2013
2Dyspnea (Shortness of Breath)
06/2023 - 09/2013
2Hyperphosphatemia
01/2020 - 10/2019
2Thrombocytopenia (Thrombopenia)
11/2017 - 12/2015
2Vomiting
01/2017 - 02/2015
2Adenocarcinoma
02/2015 - 02/2014
1Neoplasm Metastasis (Metastasis)
12/2023
1Thrombosis (Thrombus)
10/2023
1Malignant Mesothelioma
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Anemia
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Arthralgia (Joint Pain)
10/2019
1Alopecia (Baldness)
10/2019
1Peripheral Nervous System Diseases (PNS Diseases)
10/2019
1Asthenia
10/2019
1Febrile Neutropenia
01/2018
1Vision Disorders (Hemeralopia)
01/2018
1Lymphoma (Lymphomas)
01/2018
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2017
1Ovarian Neoplasms (Ovarian Cancer)
12/2015
1Paronychia
02/2015
1Mucositis
02/2015
1Sepsis (Septicemia)
02/2014
1Respiratory Insufficiency (Respiratory Failure)
02/2014
1Pneumonia (Pneumonitis)
02/2014
1Pulmonary Embolism
02/2014

Drug/Important Bio-Agent (IBA)

7Cisplatin (Platino)FDA LinkGeneric
10/2023 - 09/2013
5Carboplatin (JM8)FDA LinkGeneric
10/2019 - 06/2014
5PlatinumIBA
11/2017 - 02/2014
4Pemetrexed (MTA)FDA Link
06/2023 - 09/2013
4AfatinibIBA
06/2023 - 09/2013
4Docetaxel (Taxotere)FDA Link
10/2019 - 02/2014
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 08/2011
4ARQ 197IBA
01/2019 - 08/2011
3ErbB Receptors (EGF Receptor)IBA
01/2023 - 08/2011
3ceritinibIBA
01/2022 - 01/2017
3Tyrosine Kinase InhibitorsIBA
11/2021 - 08/2011
3Anaplastic Lymphoma KinaseIBA
11/2021 - 01/2017
3Paclitaxel (Taxol)FDA LinkGeneric
10/2019 - 06/2014
3Bevacizumab (Avastin)FDA Link
10/2014 - 02/2014
21- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
01/2023 - 01/2020
2osimertinibIBA
01/2023 - 01/2020
2CrizotinibIBA
11/2021 - 01/2018
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2020 - 10/2019
2LigandsIBA
01/2020 - 10/2019
2FP-1039IBA
01/2020 - 10/2019
2Retinaldehyde (Retinal)IBA
01/2020 - 10/2019
2nintedanibIBA
02/2015 - 02/2014
2Biomarkers (Surrogate Marker)IBA
10/2014 - 06/2014
1SteroidsIBA
12/2023
1Gefitinib (Iressa)FDA Link
12/2023
1lazertinibIBA
12/2023
1canakinumabFDA Link
10/2023
1InterleukinsIBA
10/2023
1ensartinibIBA
11/2021
1Darbepoetin alfa (Aranesp)FDA Link
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1binimetinibIBA
10/2019
1encorafenibIBA
10/2019
1Cetuximab (Erbitux)FDA Link
10/2019
1Proteins (Proteins, Gene)FDA Link
10/2019
1ganitumabIBA
11/2017
1Etoposide (VP 16)FDA LinkGeneric
11/2017
1rilotumumabIBA
11/2017
1Alanine Transaminase (SGPT)IBA
01/2017
1AZD 6244IBA
01/2017
1veliparibIBA
01/2017
1Alkylating AgentsIBA
12/2015
1AminopeptidasesIBA
12/2015
1melflufenIBA
12/2015
1Peptide Hydrolases (Proteases)FDA Link
12/2015
1Melphalan (Alkeran)FDA LinkGeneric
12/2015
1NeuropilinsIBA
06/2014
1GemcitabineFDA Link
06/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014
1methionylmethionine (Met-Met)IBA
08/2011

Therapy/Procedure

11Drug Therapy (Chemotherapy)
10/2023 - 09/2013
8Therapeutics
10/2023 - 02/2014
1Radiotherapy
01/2022
1Duration of Therapy
01/2018
1Adjuvant Chemotherapy
01/2017
1Traditional Medicine (Folk Remedies)
04/2014
1Intravenous Infusions
02/2014